← Leaderboards
Clemens R Scherzer
Brigham And Women'S Hospital
$18,559,948
Attributed
$22,002,311
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,002,311 · 11
By mechanism
U01$9,586,256 · 5
R01$6,113,047 · 2
RF1$4,760,794 · 1
K08$840,000 · 1
R21$421,094 · 1
P01$281,120 · 1
Top collaborators
- Xianjun Dong1 shared
- Mel B Feany1 shared
- Ernest Fraenkel1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Mel B Feany$26,965,920
- Kristin Schreiber$5,092,186
- Carolyn Y Ho$13,169,103
- Nan-Kuei Chen$10,454,173
- Michael G Schlossmacher$2,489,568
Others in their field
Top investigators on “Parkinson Disease”
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$92,426,001
- David M Anderson · University Of Washington$40,483,703
- Daniel M Corcos · Northwestern University$37,632,589
- Joel Synes Perlmutter · Washington University$37,192,743
- Jerrold L Vitek · University Of Minnesota$35,135,315
- Joseph B Martin · Harvard University (Medical School)$26,652,023
Research focus
Parkinson DiseaseFutureInnovationPharmaceutical PreparationsLinkGenesPreventBiological MarkersDisease ProgressionGeneticCostCase-Control StudiesBloodCohortClinical TrialsResearch PersonnelBaseNorth AmericaGene ExpressionNeuronsDesignDisorder ControlParkinson&AposDementia
Grant awards (38)
Genome-Wide Prediction of Dementia in Parkinson's Disease$583,191
R01 · FY2025 · NS · contact PI
Genome-Wide Prediction of Dementia in Parkinson's Disease$904,174
R01 · FY2022 · NS · contact PI
Genome-wide Prediction of Dementia in Parkinson Disease$325,404
R01 · FY2022 · NS · contact PI
Genome-wide Prediction of Dementia in Parkinson Disease$692,479
R01 · FY2021 · NS · contact PI
Genome-wide Prediction of Dementia in Parkinson Disease$537,098
R01 · FY2021 · NS · contact PI
Genome-wide Prediction of Dementia in Parkinson Disease$692,479
R01 · FY2020 · NS · contact PI
GBA pathway markers for Lewy body dementias$571,262
U01 · FY2020 · NS · contact PI
AI2AMP-PD: Accelerating Parkinsons Diagnosis using Multi-omics and Artificial Intelligence$537,000
U01 · FY2020 · NS
Genome-wide Prediction of Dementia in Parkinson Disease$692,479
R01 · FY2019 · NS · contact PI
GBA pathway markers for Lewy body dementias$571,262
U01 · FY2019 · NS · contact PI
Parkinson Disease: Predicting the Future$712,102
U01 · FY2018 · NS · contact PI
GBA pathway markers for Lewy body dementias$571,262
U01 · FY2018 · NS · contact PI
Integrative Multi-Omic Discovery of Proximal Mechanisms Driving Age-Dependent Neurodegeneration$4,760,794
RF1 · FY2017 · AG
Parkinson Disease: Predicting the Future$707,575
U01 · FY2017 · NS · contact PI
GBA pathway markers for Lewy body dementias$571,262
U01 · FY2017 · NS · contact PI
Parkinson Disease: Predicting the Future$705,154
U01 · FY2016 · NS · contact PI
GBA pathway markers for Lewy body dementias$571,262
U01 · FY2016 · NS · contact PI
Biomarkers for early intervention in Parkinson disease$506,654
U01 · FY2016 · NS · contact PI
Biomarkers for early intervention in Parkinson disease$506,654
U01 · FY2015 · NS · contact PI
A Next Generation of Biomarkers for Incipient Huntington Disease$505,780
U01 · FY2015 · NS · contact PI
Biomarkers for early intervention in Parkinson disease$500,458
U01 · FY2014 · NS · contact PI
A Next Generation of Biomarkers for Incipient Huntington Disease$499,563
U01 · FY2014 · NS · contact PI
A Next Generation of Biomarkers for Incipient Huntington Disease$522,558
U01 · FY2013 · NS · contact PI
Biomarkers for early intervention in Parkinson disease$506,440
U01 · FY2013 · NS · contact PI
Biomarkers for early intervention in Parkinson disease$520,008
U01 · FY2012 · NS · contact PI
Risk Marker for Parkinson's Disease: Enabling Novel Therapies$368,364
R01 · FY2011 · NS · contact PI
Risk Marker for Parkinson's Disease: Enabling Novel Therapies$372,322
R01 · FY2010 · NS · contact PI
Risk Marker for Parkinson's Disease: Enabling Novel Therapies$376,327
R01 · FY2009 · NS · contact PI
Risk Marker for Parkinson's Disease: Enabling Novel Therapies$192,168
R01 · FY2009 · NS · contact PI
Risk Marker for Parkinson's Disease: Enabling Novel Therapies$376,562
R01 · FY2008 · NS · contact PI
Genomic markers of disease progression in Huntington's disease$281,120
P01 · FY2008 · NS · contact PI
Multigene Marker of Progression in Parkinson's Disease$229,688
R21 · FY2008 · NS · contact PI
Genomic and Genetic Analysis of Parkinson's Disease$168,000
K08 · FY2008 · AG · contact PI
Multigene Marker of Progression in Parkinson's Disease$191,406
R21 · FY2007 · NS · contact PI
Genomic and Genetic Analysis of Parkinson's Disease$168,000
K08 · FY2007 · AG · contact PI
Genomic and Genetic Analysis of Parkinson's Disease$168,000
K08 · FY2006 · AG · contact PI
Genomic and Genetic Analysis of Parkinson's Disease$168,000
K08 · FY2005 · AG
Genomic and Genetic Analysis of Parkinson's Disease$168,000
K08 · FY2004 · AG